Fierce JPM Week 2025: Full Schedule

arrow_back View All Dates

9:50am PST

Panel: Biotech Markets and IPOs: Trends from 2024 and Projections for 2025

Wednesday January 15, 2025 9:50am - 10:30am PST

The biotech market made a comeback in 2024, recovering from a slump a year earlier. What will the IPO window look like in 2025? During this panel discussion, we will examine the performance of companies that went public in the second half of 2024 and how their success or challenges are impacting other startups’ decisions on whether to go public themselves

Moderators

Gabrielle Masson

Associate Editor, Fierce Biotech

Gabrielle Masson is an associate editor for Fierce Biotech. Prior to Fierce, she worked at Becker's Hospital Review, where she reported on public health and the pandemic. Gabrielle graduated from the University of Wisconsin-Madison after studying creative writing and criminal justice... Read More →

Speakers

Jeffrey Finer, MD, PhD

Chief Executive Officer and Co-Founder, Septerna

Jeffrey Finer, MD, PhD, is the Chief Executive Officer and Co-Founder at Septerna. Dr. Finer has more than 35 years of research, clinical and business experience. He has focused his career on breakthrough innovations that have included moving several first-in-class drugs into clinical... Read More →

Chirag D. Surti

Executive Director, Morgan Stanley

Maha Katabi

General Partner, Sofinnova Investments

Troy Ignelzi

CFO, Rapport Therapeutics

Troy has nearly two decades of financial leadership experience in the biotech and pharmaceuticals sectors. Over the course of his career, Troy has raised an impressive $4 billion-plus in capital for life science companies. Most recently, he was Chief Financial Officer at Karuna Therapeutics... Read More →

Wednesday January 15, 2025 9:50am - 10:30am PST
Hyatt Regency San Francisco

Panel

Qtag Featured

11:40am PST

Panel: Unlocking the Power of Healthcare Data: Advancing Access and Connectivity to Drive Patient Outcomes

Wednesday January 15, 2025 11:40am - 12:20pm PST

Hyatt Regency San Francisco

As healthcare embraces a more connected future, the need for real-time, global data access has become vital to bridging gaps in patient care and streamlining drug development. This panel delves into the challenges and opportunities in democratizing healthcare data, with a focus on integrated solutions and strategies that address data fragmentation and enable swift access to diverse patient and provider demographics. Join us to discover how democratizing healthcare data will shape the future of global patient care and catalyze advancements in the biopharma industry.

Moderators

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences

Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →

Speakers

Jeffrey Helterbrand, Ph.D.

SVP, Data Sciences, Roche

Jeff is a Senior Vice President in PD Data Sciences (formerly Biometrics) at Roche. Data Sciences at Roche includes statisticians, patient-centered outcomes researchers, statistical programmers, clinical data managers, and medical data and information solution teams. Jeff is a member... Read More →

Wednesday January 15, 2025 11:40am - 12:20pm PST
Hyatt Regency San Francisco

Panel

2:40pm PST

Panel: Cell & Gene Therapy: Challenges, Trends and Technologies

Wednesday January 15, 2025 2:40pm - 3:20pm PST

Hyatt Regency San Francisco

With advancements in platform technologies and automation, the cell and gene therapy space is poised for changes. During this panel discussion, industry leaders will explore challenges and share insights on navigating regulatory hurdles, optimizing manufacturing and leveraging emerging technologies to address broader disease states.

Moderators

Fraiser Kansteiner

Staff Writer, Fierce Pharma

Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →

Speakers

Dr. Nadir Mahmood

President, Nkarta

Dr. Nadir Mahmood serves as President of Nkarta, where he is responsible for driving the company’s strategic focus, business excellence, and technical success. He previously served as the Chief Executive Officer of Rezo Therapeutics, a private-stage drug discovery company. Prior... Read More →

Richard Wilson

SVP, Primary Focus Lead Genetic Regulation, Astellas

Richard Wilson, Senior Vice President, Primary Focus Lead of Genetic Regulation at Astellas Gene Therapies, is responsible for setting and leading the gene therapy strategy for Astellas’ Primary Focus Genetic Regulation. Richard joined Astellas Gene Therapies (formerly Audentes... Read More →

Christopher Arendt, Ph.D.

Chief Scientific Officer, Head of Research, Takeda

Based at Takeda’s Cambridge, Massachusetts, R&D campus, Christopher Arendt is responsible for oversight of Takeda’s Research and Early Development portfolio across Takeda’s core therapeutic areas of Gastroenterology andInflammation, Oncology, and Neuroscience. Prior to his... Read More →

Cindy Perettie

Executive Vice President, Kite, a Gilead Company

Cindy Perettie serves as Executive Vice President of Kite, a Gilead Company, and is responsible for overseeing the cell therapy business. Cindy joined Kite in 2023 with more than 20 years of scientific and commercial leadership experience in global biopharmaceutical organizations... Read More →

Wednesday January 15, 2025 2:40pm - 3:20pm PST
Hyatt Regency San Francisco

Panel

Qtag Featured